Our website and emails are changing, but our people, service, and quality are not!
In 2019 iMedX will be completing the final phase of the OzeScribe acquisition in Australia by phasing out the OzeScribe brand. This is to better align the branding across multiple Clinical Information solutions which we offer in Australia, New Zealand and the United States – not just transcription!